Brosseron F, Traschütz A, Widmann CN, Kummer MP, Tacik P, Santarelli F, Jessen F, Heneka MT. Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease. Alzheimers Res Ther. 2018 Feb 26;10(1):25. PubMed.
AlzBiomarker Database
Meta-Analysis
- AD vs CTRL : MCP-1 (CSF)
- CTRL vs AD : MCP-1 (CSF)
- FTD vs AD : MCP-1 (CSF)
- PD vs AD : MCP-1 (CSF)
- AD vs CTRL : sTREM2 (CSF)
- CTRL vs AD : sTREM2 (CSF)
- DLB vs AD : sTREM2 (CSF)
- FTD vs AD : sTREM2 (CSF)
- PD vs AD : sTREM2 (CSF)
Curated Study Data
Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
---|---|---|---|---|
MCP-1 (CSF) |
AD (116) |
342 ± 96 pg/mL |
Electrochemiluminescence; V-PLEX Human Biomarker 40-Plex Kit; Meso Scale Discovery |
McKhann et al., 2011 |
MCP-1 (CSF) |
CTRL- Other Controls (85) |
323 ± 112 pg/mL |
Electrochemiluminescence; V-PLEX Human Biomarker 40-Plex Kit; Meso Scale Discovery |
|
MCP-1 (CSF) |
FTD (20) |
336 ± 112 pg/mL |
Electrochemiluminescence; V-PLEX Human Biomarker 40-Plex Kit; Meso Scale Discovery |
Gorno-Tempini et al., 2011 |
MCP-1 (CSF) |
PD (16) |
335 ± 73 pg/mL |
Electrochemiluminescence; V-PLEX Human Biomarker 40-Plex Kit; Meso Scale Discovery |
Hughes et al., 1992 |
sTREM2 (CSF) |
AD (116) |
4315 ± 2235 pg/mL |
Electrochemiluminescence; Other/Not Specified; In-house |
McKhann et al., 2011 |
sTREM2 (CSF) |
CTRL- Other Controls (85) |
2994 ± 2269 pg/mL |
Electrochemiluminescence; Other/Not Specified; In-house |
|
sTREM2 (CSF) |
DLB (11) |
4222 ± 1675 pg/mL |
Electrochemiluminescence; Other/Not Specified; In-house |
|
sTREM2 (CSF) |
FTD (20) |
3343 ± 2031 pg/mL |
Electrochemiluminescence; Other/Not Specified; In-house |
Gorno-Tempini et al., 2011 |
sTREM2 (CSF) |
PD (16) |
4186 ± 2243 pg/mL |
Electrochemiluminescence; Other/Not Specified; In-house |
Hughes et al., 1992 |
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.